Depression screening in Black Americans with multiple sclerosis

References

• Bamer, A.M., Cetin, K., Johnson, K., Gibbons, L., & Ehde, D. (2008). Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis. General Hospital Psychiatry, 30, 311–317.
   PubMed Web of Science ®Google Scholar
• Beck, A.T., Steer, R.A., & Brown, G.K. (2000). BDI-fast screen for medical patients: Manual. San Antonio, TX: Psychological Corporation.
   Google Scholar
• Bell, C.C., & Mehta, H. (1980). The misdiagnosis of black patients with manic depressive illness. Journal of the National Medical Association, 72, 141–145.
   PubMedGoogle Scholar
• Benedict, R.H., Fishman, I., McClellan, M.M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Multiple sclerosis, 9, 393–396.
   PubMed Web of Science ®Google Scholar
• Borowsky, S.J., Rubenstein, L.C., Meredith, L.S., Camp, P., Jackson-Triche, M., & Wells, K. (2000). Who is at risk for nondetection of mental health problems in primary care? Journal of General Internal Medicine, 15, 381–388.
   PubMed Web of Science ®Google Scholar
• Bottonari, K.A., & Stepleman, L. (2010). Improving access to mental health services via a clinic-wide mental health intervention in a Southeastern US infectious disease clinic. AIDS Care, 22, 133–136.
   PubMed Web of Science ®Google Scholar
• Brown, C., Schulberg, H.C., & Madonia, M.J. (1996). Clinical presentations of major depression by African Americans and Whites in primary medical care practice. Journal of Affective Disorders, 41, 181–191.
   PubMed Web of Science ®Google Scholar
• Brown, C., Schulberg, H.C., Sacco, D., Perel, J.M., & Houck, P.R. (1999). Effectiveness of treatments for major depression in primary medical care: A post hoc analysis of outcomes for African Americans and White patients. Journal of Affect Disorders, 53, 185–192.
   PubMed Web of Science ®Google Scholar
• Cooper-Patrick, L., Crum, R., & Ford, D. (1994). Characteristics of patients with major depression who received care in general medical and specialty mental health settings. Medical Care, 32, 15–24.
   PubMed Web of Science ®Google Scholar
• Cooper-Patrick, L., Gallo, J., Powe, N., Stenwachs, D., Eaton, W., & Ford, D. (1999). Mental health service utilization by African Americans and whites: The Baltimore epidemiological catchment area follow-up. Medical Care, 37, 1034–1045.
   PubMed Web of Science ®Google Scholar
• Cree, B.A., Stuart, W.H., Tornatore, C.S., Jeffery, D.R., Pace, A.L., & Cha, C.H. (2011). Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis. Archives of Neurology, 68, 464–468.
   PubMed Web of Science ®Google Scholar
• D’Alisa, S., Miscio, G., Baudo, S., Simone, A., Tesio, L., & Mauro, A. (2006). Depression is the main determinant of quality of life in multiple sclerosis: A classification-regression (CART) study. Disability and Rehabilitation, 28, 307–314.
   PubMed Web of Science ®Google Scholar
• Ford, D.E., Kamerow, D.B., & Thompson, J.W. (1988). Who talks to physicians about mental health and substance abuse problems? Journal of General Internal Medicine, 3, 33–369.
   Google Scholar
• Goldman Consensus Group (2005). The goldman consensus statement on depression in multiple sclerosis. Multiple sclerosis, 11, 328–337.
   PubMed Web of Science ®Google Scholar
• Joffe, R.T., Lippert, G.P., Gray, T.A., Sawa, G., & Hovarth. (1987). Mood disorder and multiple sclerosis. Archives of General Neurology, 44, 376–378.
   PubMed Web of Science ®Google Scholar
• Kantarci, O., & Wingerchuk, D. (2006). Epidemiology and natural history of multiple sclerosis: New insights. Current Opinion in Neurology, 19, 248–254.
   PubMed Web of Science ®Google Scholar
• Klineova, S., Nicholas, J., & Walker, A. (2012). Response to disease modifying therapies in African Americans with multiple sclerosis. Ethnicity & Disease, 22, 221–225.
   PubMed Web of Science ®Google Scholar
• Kurtzke, J.F., Beebe, E.W., & Norman, J.E. (1979). Epidemiology and multiple sclerosis in US veterans. Neurology, 29, 1228–1235.
   PubMed Web of Science ®Google Scholar
• Marrie, R.A., Cutter, G., Tyry, T., Vollmer, T., & Compagnolo, D. (2006). Does multiple sclerosis-related disability differ between races? Neurology, 66, 1235–1240.
   PubMed Web of Science ®Google Scholar
• Minden, S.L. (2000). Depression and mood disorders in multiple sclerosis: Diagnosis and treatment. Journal of Neurovirology, 6(suppl 2), S160–S167.
   PubMed Web of Science ®Google Scholar
• Minden, S.L., Hoaglin, D.L., Hadden, B.A., Frankel, M.S., Robbins, T., & Perloff, J. (2008). Access to and utilization of neurologists by people with multiple sclerosis. Neurology, 70, 1141–1149.
   PubMed Web of Science ®Google Scholar
• Minden, S.L., & Schiffer, R.B. (1991). Depression and mood disorders in multiple sclerosis. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 4, 62–77.
   Google Scholar
• Mohr, D.C., Goodkin, D.E., Likosky, W., Gatto, N., Baumann, K.A., & Rudick, R.A. (1997). Treatment of depression improves adherence to interferon Beta-1b therapy for multiple sclerosis. Archives of Neurology, 54, 531–533.
   PubMed Web of Science ®Google Scholar
• Mohr, D.C., Hart, S.L., Fonareva, I., & Tasch, E.S. (2006). Treatment of depression for patients with multiple sclerosis in neurology clinics. Multiple sclerosis, 12, 204–208.
   PubMed Web of Science ®Google Scholar
• Poole, H., Bramwell, R., & Murphy, P. (2009). The utility of the Beck Depression Inventory Fast Screen (BDI-FS) in a pain clinic population. European Journal of Pain, 13(8), 865–869.
   PubMed Web of Science ®Google Scholar
• Rinker, J.R., Trinkaus, K., Naismith, R.T., & Cross, A.H. (2007). Higher IgG index found in African-Americans versus Caucasians with multiple sclerosis. Neurology, 69, 68–72.
   PubMed Web of Science ®Google Scholar
• Sadovnick, A.D., Remick, R.A., Allen, J., Swartz, E., Yee, I.M., Eisen, K., & Paty, D.W. (1996). Depression and multiple sclerosis. American Journal of Psychiatry, 140, 1498–1500.
   Google Scholar
• Skaer, T.L., Sclar, D.A., Robinson, L.M., & Galin, R.S. (2000). Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: An assessment of office-based visits in the United States, 1992–1997. Clinical Therapeutics, 22, 1575–1589.
   PubMed Web of Science ®Google Scholar
• Sleath, B., Svarstad, B., & Roter, D.L. (1998). Patient race and psychotropic prescribing during medical encounters. Patient Education and Counseling, 34, 227–238.
   PubMed Web of Science ®Google Scholar
• Stepleman, L.M., Hann, G., Santos, M., & House, A.S. (2006). Reaching underserved HIV-positive individuals using patient-centered psychological consultation. Professional Psychology: Research & Practice, 37, 75–82.
   Web of Science ®Google Scholar
• Stepleman, L., Jump, R., Shelton, S., & Hughes, M. (2009). Psychological consultation services at a multiple sclerosis clinic. International Journal of MS Care, 11, 180–186.
   Google Scholar
• Thompson, A.J., Toosey, A.T., & Ciccarelli, O. (2010). Pharmacological management of symptoms in multiple sclerosis: Current approaches and future directions. The Lancet, 9, 1182–1199.
   Web of Science ®Google Scholar
• Williams, J.W., Pignone, M., Ramirez, G., & Perez Stellato, C.P. (2002). Identifying depression in primary care: A literature synthesis of case-finding instruments. General Hospital Psychiatry, 24, 225–237.
   PubMed Web of Science ®Google Scholar
• Wohl, M., Lesser, I., & Smith, M. (1997). Clinical presentations of depression in African Americans and white outpatients. Cultural Diversity and Mental Health, 3, 279–284.
   PubMedGoogle Scholar